Therefore, understanding the detailed structural and molecular mechanisms of Cdc7 activation by Dbf4, the docking of the DDK onto the DH, and the activation of DH by DDK would be invaluable for developing anti-cancer drugs. This evidence concerns the gene DBF4 and cancer.